title: Rebound psychiatric and physical symptoms after gabapentin discontinuation.
authors.forename: G
authors.initials: G
authors.lastname: Corá-Locatelli
authors.forename: B D
authors.initials: BD
authors.lastname: Greenberg
authors.forename: J D
authors.initials: JD
authors.lastname: Martin
authors.forename: D L
authors.initials: DL
authors.lastname: Murphy
mesh_terms: D000085:Acetates / Q000009:adverse effects* / Q000627:therapeutic use; D000588:Amines; D000927:Anticonvulsants / Q000009:adverse effects* / Q000627:therapeutic use; D003509:Cyclohexanecarboxylic Acids; D004359:Drug Therapy, Combination; D005473:Fluoxetine / Q000627:therapeutic use*; D000077206:Gabapentin; D006801:Humans; D009771:Obsessive-Compulsive Disorder / Q000139:chemically induced* / Q000188:drug therapy; D012008:Recurrence; D013375:Substance Withdrawal Syndrome / Q000209:etiology*; D005680:gamma-Aminobutyric Acid
chemical_list: D000085:Acetates; D000588:Amines; D000927:Anticonvulsants; D003509:Cyclohexanecarboxylic Acids; D005473:Fluoxetine; D005680:gamma-Aminobutyric Acid; D000077206:Gabapentin